Dr. Bernard Le Foll is a senior scientist specializing in addiction within the Institute for Mental Health Policy Research at CAMH. Additionally, Dr. Bernard Le Foll is chair of addiction psychiatry within the Department of Psychiatry of University of Toronto and a professor in the departments of Family and Community Medicine, Pharmacology and Toxicology, Psychiatry, Institute of Medical Sciences and the Dalla Lana School of Public Health. Dr. Bernard Le Foll received specialized training in drug addiction and behavioral and cognitive therapy at Paris University in France. He has written treatment guidelines and has been the coordinator of clinical trials. He obtained a PhD in pharmacology at INSERM and completed a Post-doctoral Fellowship at the National Institutes of Health. He has received scientific prizes and awards from the Canadian Institutes for Health Research, the National Institutes of Health, the French Academy of Medicine, the American College for Neuropsychopharmacology, the College on Problems on Drug Dependence, the Society for Research on Nicotine and Tobacco, the Brain and Behavior Foundation, Pfizer, OPGRC, the Ontario Lung Association, and the Heart and Stroke Foundation. The goal of his research is to improve treatment of drug addiction. For this purpose, various approaches are used such as clinical trials, laboratory experiments, and multi-disciplinary basic research approaches. The goal is to develop novel therapeutic strategies in clinical populations.